470 related articles for article (PubMed ID: 17245212)
1. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.
Czesnikiewicz-Guzik M; Loster B; Bielanski W; Guzik TJ; Konturek PC; Zapala J; Konturek SJ
J Clin Gastroenterol; 2007 Feb; 41(2):145-51. PubMed ID: 17245212
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia.
Czesnikiewicz-Guzik M; Bielanski W; Guzik TJ; Loster B; Konturek SJ
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():77-89. PubMed ID: 16340041
[TBL] [Abstract][Full Text] [Related]
3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
4. Oral cavity as permanent reservoir of Helicobacter pylori and potential source of reinfection.
Pytko-Polonczyk J; Konturek SJ; Karczewska E; Bielański W; Kaczmarczyk-Stachowska A
J Physiol Pharmacol; 1996 Mar; 47(1):121-9. PubMed ID: 8777292
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the presence of Helicobacter pylori in the oral cavity and gastric in the stomach.
Loster BW; Majewski SW; Cześnikiewicz-Guzik M; Bielanski W; Pierzchalski P; Konturek SJ
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():91-100. PubMed ID: 17033108
[TBL] [Abstract][Full Text] [Related]
7. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
Masaoka T; Suzuki H; Imaeda H; Hosoda H; Ohara T; Morishita T; Ishii H; Kangawa K; Hibi T
Hepatogastroenterology; 2005; 52(61):1-4. PubMed ID: 15782980
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
9. Association of the presence of Helicobacter pylori in the oral cavity and in the stomach.
Cześnikiewicz-Guzik M; Karczewska E; Bielański W; Guzik TJ; Kapera P; Targosz A; Konturek SJ; Loster B
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():105-15. PubMed ID: 15608365
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa.
Tatsuguchi A; Miyake K; Gudis K; Futagami S; Tsukui T; Wada K; Kishida T; Fukuda Y; Sugisaki Y; Sakamoto C
Am J Gastroenterol; 2004 Nov; 99(11):2121-7. PubMed ID: 15554990
[TBL] [Abstract][Full Text] [Related]
11. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
[TBL] [Abstract][Full Text] [Related]
12. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
13. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans.
Isomoto H; Ueno H; Saenko VA; Mondal MS; Nishi Y; Kawano N; Ohnita K; Mizuta Y; Ohtsuru A; Yamashita S; Nakazato M; Kohno S
Am J Gastroenterol; 2005 Aug; 100(8):1711-20. PubMed ID: 16086706
[TBL] [Abstract][Full Text] [Related]
14. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
15. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy.
Gebara EC; Faria CM; Pannuti C; Chehter L; Mayer MP; Lima LA
J Clin Periodontol; 2006 May; 33(5):329-33. PubMed ID: 16634953
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between Helicobacter pylori in oral cavity and the Hp infection in stomach].
Hou HL; Meng HX; Hu WJ; Wang JW
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):327-9. PubMed ID: 14680575
[TBL] [Abstract][Full Text] [Related]
18. Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.
Karczewska E; Konturek JE; Konturek PC; Cześnikiewicz M; Sito E; Bielański W; Kwiecień N; Obtułowicz W; Ziemniak W; Majka J; Hahn EG; Konturek SJ
Dig Dis Sci; 2002 May; 47(5):978-86. PubMed ID: 12018924
[TBL] [Abstract][Full Text] [Related]
19. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
Kato S; Ozawa K; Koike T; Sekine H; Ohara S; Minoura T; Iinuma K
Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
[TBL] [Abstract][Full Text] [Related]
20. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
